Safety and efficacy of combination olaparib (O) and temozolomide (T) in small cell lung cancer (SCLC)
- Resource Type
- Source
- Journal of Clinical Oncology. 36:8571-8571
- Subject
0301 basic medicine Cancer Research medicine.medical_treatment Poly ADP ribose polymerase Malignancy Olaparib 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Overall response rate medicine Polymerase Chemotherapy Temozolomide biology business.industry medicine.disease respiratory tract diseases 030104 developmental biology Oncology chemistry 030220 oncology & carcinogenesis Cancer research biology.protein Non small cell business medicine.drug - Language
- ISSN
- 1527-7755
0732-183X